Sollte bald der endgültige Vertrag geschlossen werden, sollte die Aktie einen Sprung nach oben machen. In Berlin schönes Orderbuch
Newtech Creates Advisory Board
VANCOUVER, BRITISH COLUMBIA, Apr 30, 2004 (CCNMatthews via COMTEX) -- Newtech Resources Ltd. ("Newtech") (OTCBB: NTHR)(Berlin: NWE Security No.
157768) today is pleased to announce that it has created an advisory board consisting of two individuals who will assist the company with future financing and marketing.
Joining the Newtech team is Mr. Kjell Jagalid, of Zurich, Switzerland, and Mr. Rick Yanus of San Diego, California.
Kjell Jagelid of Zurich Switzerland has over twenty-five years experience in international management with negotiations in engineering, financial, banking, mergers and business agreements. In addition, Kjell has over 10 years public company experience in the United States and Europe. His network of business contacts extends internationally. Kjell has also filed over 15 patents, which have been successfully used worldwide in the mechanical and construction industries. Kjell has an Equivalent Bachelors Degree in Finance at PHF Goteborg, Sweden and an Equivalent Bachelors Degree, (Civil and Mechanical Engineering) at GTI, Sweden. Kjell is fluent in English, Swedish, (all Scandinavian languages) and proficient in German.
Rick Yanus has over twenty years experience in the pharmaceutical industry. With a background as a clinical pharmacist, Rick specialized in diabetes by also becoming a board certified diabetes educator (CDE). Rick's experience in the sales and marketing of key diabetes medications includes some of the most successful drugs ever launched for diabetes: Glucophage, Avandia, Rezulin and Diabeta. Rick was involved in the strategic planning and launch of other key medications: Lipitor, Plavix, Avapro, Vicodin and twelve other medications. Rick created the newsletter DiaBeat, in 1997 to help educate patients and allied health professionals on key topics in diabetes and co-authored a text for educating pharmacists in the United States on diabetes complications. Rick has an MBA in marketing from Southern New Hampshire University as well as a BS-Pharmacy from Albany College of Pharmacy in Albany, NY. Rick is a registered pharmacist (RPh) in both New York and New Hampshire.
Newtech is a public company; its common shares trade on the OTCBB under the ticker symbol "NTHR" and on the Berlin Stock Exchange under the symbol "NWE".
A number of statements contained in this press release are forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Act of 1995. These forward looking statements involve a number of risks and uncertainties, including timely development, and market acceptance of products and technologies, competitive market conditions, successful integration of acquisitions and the ability to secure additional sources of financing. The actual results of Newtech may achieve could differ materially from any forward-looking statements due to such risks and uncertainties. Newtech encourages the public to read the information provided here in conjunction with its most recent filings on Form 10KSB and Form 10QSB. Newtech's public filings may be viewed at www.sec.gov.
CONTACT: Newtech Resources Ltd.
Ross Wilmot
President
(604) 602 1717
Email: rwilmot@ipm.bc.ca
Copyright (C) 2004, CCNMatthews. All rights reserved.
&a=157768&b=0&banner_ref=HASH(0x9e5273c)&zeitraum=5&ind_volume=ON&zoom.x=0&ISSE=v2-512204-695754-2570-146515&v2-512204-695754-2570-146515=ARRAY(0x9e66da8)&zeitbis=&bname=&bis=1083042609.14102&cookies=HASH(0x9e594f4)&req_host=ARRAY(0x9fe830c)&zeitvon=0&von=0)
